The incidence of mild cognitive impairment: A systematic review and data synthesis

Cai Gillis, Fariba Mirzaei, Michele Potashman, M Arfan Ikram, Nancy Maserejian, Cai Gillis, Fariba Mirzaei, Michele Potashman, M Arfan Ikram, Nancy Maserejian

Abstract

Introduction: Incidence estimates of mild cognitive impairment (MCI) range widely. We obtained contemporary age-specific MCI incidence rates and examined sources of heterogeneity.

Methods: We conducted a systematic review of population-based studies from the Americas, Europe, and Australia using restrictive inclusion criteria to limit heterogeneity. Incidence was examined using 5-year age categories for MCI and amnestic/nonamnestic subtypes. Data were synthesized using quantitative and qualitative descriptive analyses and quantitative meta-analyses.

Results: Meta-analysis estimates (95% CI) of MCI incidence per 1000 person-years were 22.5 (5.1-51.4) for ages 75-79y, 40.9 (7.7-97.5) for ages 80-84y, and 60.1 (6.7-159.0) for ages 85+y. Despite restrictive inclusion criteria, considerable heterogeneity (measured by I2) remained. Meta-analysis findings and simple descriptive statistics were consistent and supported by qualitative review.

Discussion: Heterogeneity in MCI incidence estimates persisted across age-specific estimates from population samples, likely reflecting differences in populations and methods. Incidence rate ranges are important to consider with summary point estimates.

Keywords: Alzheimer's disease; Diagnosis; Incidence; Meta-analysis; Mild cognitive impairment; Systematic literature review.

Figures

Fig. 1
Fig. 1
Process of identification and exclusion of studies for multiprong qualitative and quantitative approach. Abbreviations: aMCI, amnestic mild cognitive impairment; CIND, cognitive impairment, no dementia; MCI, mild cognitive impairment; naMCI, nonamnestic cognitive impairment; SCC, subjective cognitive complaint. *Reasons for full-text exclusions: (Phase 2.2)—disease definition not clearly described; (Phase 2.3)—study is not related to or is not focused on MCI, aMCI, or naMCI incidence, is focused solely on a type of MCI due to a specific disease (e.g., Parkinson’s disease, Lewy body disease), or does not report MCI, aMCI, or naMCI incidence; (Phase 2.4)—sampling method not clearly described; (Phase 2.6)—convenience sample or disease-based sample; (Phase 2.7)—if two studies use the same data set or patient population for the same parameter for the same time period, select the study with the longer follow-up period; (Phase 2.8)—review paper (include the cited studies instead); (Phase 2.12)—clinical trials; (Phase 2.14)—region outside of inclusion area (Americas, Europe, and Australia). †Reasons for multiprong analyses exclusions: age bands—estimates fell outside of our specified age bands; CIND—estimates are for cognitive impairment, no dementia instead of MCI; sex stratified—estimates are only provided stratified by sex; SCC—modified MCI criteria to exclude subjective cognitive concern as a criterion.
Fig. 2
Fig. 2
Example of a patient funnel for decision-makers, estimating the incidence of MCI in the patient population with Alzheimer's disease pathology. Abbreviations: AD, Alzheimer's disease; MCI, mild cognitive impairment. *Refers to application of case identification correction factor to account for the patient journey.

References

    1. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270–279.
    1. Alzheimer's Association 2018 Alzheimer's disease facts and figures. Alzheimers Dement. 2018;14:367–429.
    1. Jansen W.J., Ossenkoppele R., Knol D.L., Tijms B.M., Scheltens P., Verhey F.R. Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis. JAMA. 2015;313:1924–1938.
    1. Petersen R.C., Lopez O., Armstrong M.J., Getchius T.S.D., Ganguli M., Gloss D. Practice guideline update summary: mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90:126–135.
    1. Ward A., Arrighi H.M., Michels S., Cedarbaum J.M. Mild cognitive impairment: Disparity of incidence and prevalence estimates. Alzheimers Dement. 2012;8:14–21.
    1. Roberts R.O., Geda Y.E., Knopman D.S., Cha R.H., Pankratz V.S., Boeve B.F. The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic Study of Aging. Neurology. 2012;78:342–351.
    1. Luck T., Luppa M., Briel S., Riedel-Heller S.G. Incidence of mild cognitive impairment: A systematic review. Dement Geriatr Cogn Disord. 2010;29:164–175.
    1. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–1992.
    1. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol. 1999;56:303–308.
    1. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O. Mild cognitive impairment--beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–246.
    1. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012.
    1. Luck T., Luppa M., Briel S., Matschinger H., Konig H.H., Bleich S. Mild cognitive impairment: Incidence and risk factors: Results of the leipzig longitudinal study of the aged. J Am Geriatr Soc. 2010;58:1903–1910.
    1. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194.
    1. Nyaga V.N., Arbyn M., Aerts M. Metaprop: A Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72:39.
    1. Higgins J.P.T., Green S., editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 The Cochrane Collaboration. 2011. Available at:
    1. Anstey K.J., Cherbuin N., Christensen H., Burns R., Reglade-Meslin C., Salim A. Follow-up of mild cognitive impairment and related disorders over four years in adults in their sixties: The PATH Through Life Study. Dement Geriatr Cogn Disord. 2008;26:226–233.
    1. Anstey K.J., Cherbuin N., Eramudugolla R., Sargent-Cox K., Easteal S., Kumar R. Characterizing mild cognitive disorders in the young-old over 8 years: Prevalence, estimated incidence, stability of diagnosis, and impact on IADLs. Alzheimers Dement. 2013;9:640–648.
    1. Brodaty H., Heffernan M., Kochan N.A., Draper B., Trollor J.N., Reppermund S. Mild cognitive impairment in a community sample: The Sydney Memory and Ageing Study. Alzheimers Dement. 2013;9:310–317.e1.
    1. Chaves M.L., Camozzato A.L., Godinho C., Piazenski I., Kaye J. Incidence of mild cognitive impairment and Alzheimer disease in Southern Brazil. J Geriatr Psychiatry Neurol. 2009;22:181–187.
    1. Elmstahl S., Widerstrom E. Orthostatic intolerance predicts mild cognitive impairment: Incidence of mild cognitive impairment and dementia from the Swedish general population cohort Good Aging in Skane. Clin Interv Aging. 2014;9:1993–2002.
    1. Ganguli M., Fu B., Snitz B.E., Hughes T.F., Chang C.C. Mild cognitive impairment: Incidence and vascular risk factors in a population-based cohort. Neurology. 2013;80:2112–2120.
    1. Gao S., Unverzagt F.W., Hall K.S., Lane K.A., Murrell J.R., Hake A.M. Mild cognitive impairment, incidence, progression, and reversion: Findings from a community-based cohort of elderly African Americans. Am J Geriatr Psychiatry. 2014;22:670–681.
    1. Lo Giudice D., Smith K., Fenner S., Hyde Z., Atkinson D., Skeaf L. Incidence and predictors of cognitive impairment and dementia in Aboriginal Australians: A follow-up study of 5 years. Alzheimers Dement. 2016;12:252–261.
    1. Luchsinger J.A., Reitz C., Patel B., Tang M.X., Manly J.J., Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007;64:570–575.
    1. Marengoni A., Fratiglioni L., Bandinelli S., Ferrucci L. Socioeconomic status during lifetime and cognitive impairment no-dementia in late life: The population-based aging in the Chianti Area (InCHIANTI) Study. J Alzheimers Dis. 2011;24:559–568.
    1. Plassman B.L., Langa K.M., McCammon R.J., Fisher G.G., Potter G.G., Burke J.R. Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol. 2011;70:418–426.
    1. Ravaglia G., Forti P., Montesi F., Lucicesare A., Pisacane N., Rietti E. Mild cognitive impairment: Epidemiology and dementia risk in an elderly Italian population. J Am Geriatr Soc. 2008;56:51–58.
    1. Roberts R.O., Cha R.H., Mielke M.M., Geda Y.E., Boeve B.F., Machulda M.M. Risk and protective factors for cognitive impairment in persons aged 85 years and older. Neurology. 2015;84:1854–1861.
    1. Solfrizzi V., Panza F., Colacicco A.M., D'Introno A., Capurso C., Torres F. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology. 2004;63:1882–1891.
    1. Sprung J., Roberts R.O., Knopman D.S., Olive D.M., Gappa J.L., Sifuentes V.L. Association of mild cognitive impairment with exposure to general anesthesia for surgical and nonsurgical procedures: a population-based study. Mayo Clin Proc. 2016;91:208–217.
    1. Wilson R.S., Schneider J.A., Arnold S.E., Tang Y., Boyle P.A., Bennett D.A. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 2007;64:802–808.
    1. Busse A., Bischkopf J., Riedel-Heller S.G., Angermeyer M.C. Mild cognitive impairment: Prevalence and predictive validity according to current approaches. Acta Neurol Scand. 2003;108:71–81.
    1. Caracciolo B., Palmer K., Monastero R., Winblad B., Backman L., Fratiglioni L. Occurrence of cognitive impairment and dementia in the community: A 9-year-long prospective study. Neurology. 2008;70:1778–1785.
    1. Katz M.J., Lipton R.B., Hall C.B., Zimmerman M.E., Sanders A.E., Verghese J. Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: A report from the Einstein Aging Study. Alzheimer Dis Assoc Disord. 2012;26:335–343.
    1. Larrieu S., Letenneur L., Orgogozo J.M., Fabrigoule C., Amieva H., Le Carret N. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594–1599.
    1. Manly J.J., Tang M.X., Schupf N., Stern Y., Vonsattel J.P., Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol. 2008;63:494–506.
    1. Petersen R.C., Caracciolo B., Brayne C., Gauthier S., Jelic V., Fratiglioni L. Mild cognitive impairment: A concept in evolution. J Intern Med. 2014;275:214–228.
    1. Sachdev P.S., Lipnicki D.M., Kochan N.A., Crawford J.D., Thalamuthu A., Andrews G. The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: The COSMIC Collaboration. PLoS One. 2015;10:e0142388.
    1. Au B., Dale-McGrath S., Tierney M.C. Sex differences in the prevalence and incidence of mild cognitive impairment: A meta-analysis. Ageing Res Rev. 2017;35:176–199.
    1. Petersen R.C. Early diagnosis of Alzheimer's disease: Is MCI too late? Curr Alzheimer Res. 2009;6:324–330.
    1. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198–205.
    1. Backman L., Jones S., Berger A.K., Laukka E.J., Small B.J. Multiple cognitive deficits during the transition to Alzheimer's disease. J Intern Med. 2004;256:195–204.
    1. Frank L., Lloyd A., Flynn J.A., Kleinman L., Matza L.S., Margolis M.K. Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants. Int Psychogeriatr. 2006;18:151–162.
    1. Onor M.L., Trevisiol M., Negro C., Aguglia E. Different perception of cognitive impairment, behavioral disturbances, and functional disabilities between persons with mild cognitive impairment and mild Alzheimer's disease and their caregivers. Am J Alzheimers Dis Other Dement. 2006;21:333–338.
    1. Kuo L.M., Shyu Y.I. Process of ambivalent normalisation: experience of family caregivers of elders with mild cognitive impairment in Taiwan. J Clin Nurs. 2010;19:3477–3484.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe